TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Neurotrauma Research Sweden Nrs AB
Closing information (x1000 EUR)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover | 43 | 66 | 77 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | -16 | 504 | 244 |
EBITDA | -14 | 34 | 244 |
Total assets | 660 | 743 | 308 |
Current assets | 31 | 53 | 77 |
Current liabilities | 19 | 3 | 49 |
Equity capital | 642 | 740 | 258 |
- share capital | 9 | 10 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency | 97.3% | 99.6% | 83.8% |
Turnover per employee | 43 | 66 | 77 |
Profit as a percentage of turnover | -37.2% | 763.6% | 316.9% |
Return on assets (ROA) | -2.4% | 67.8% | 79.2% |
Current ratio | 163.2% | 1766.7% | 157.1% |
Return on equity (ROE) | -2.5% | 68.1% | 94.6% |
Change turnover | -17 | -10 | 3 |
Change turnover % | -29% | -13% | 3% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.